Evergreen Capital Management LLC Purchases Shares of 39,022 Walgreens Boots Alliance Inc (WBA)

Evergreen Capital Management LLC purchased a new position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 39,022 shares of the pharmacy operator’s stock, valued at approximately $2,555,000.

A number of other institutional investors and hedge funds have also bought and sold shares of WBA. Parkside Investments LLC raised its stake in Walgreens Boots Alliance by 3.0% during the fourth quarter. Parkside Investments LLC now owns 24,806 shares of the pharmacy operator’s stock worth $1,801,000 after purchasing an additional 715 shares during the period. BTIM Corp. raised its stake in Walgreens Boots Alliance by 3.5% during the fourth quarter. BTIM Corp. now owns 21,457 shares of the pharmacy operator’s stock worth $1,558,000 after purchasing an additional 725 shares during the period. Eads & Heald Investment Counsel raised its stake in Walgreens Boots Alliance by 3.6% during the fourth quarter. Eads & Heald Investment Counsel now owns 21,249 shares of the pharmacy operator’s stock worth $1,543,000 after purchasing an additional 748 shares during the period. Carnegie Capital Asset Management LLC raised its stake in Walgreens Boots Alliance by 3.3% during the fourth quarter. Carnegie Capital Asset Management LLC now owns 24,680 shares of the pharmacy operator’s stock worth $1,783,000 after purchasing an additional 790 shares during the period. Finally, Alpha Omega Wealth Management LLC raised its stake in Walgreens Boots Alliance by 100.0% during the first quarter. Alpha Omega Wealth Management LLC now owns 1,600 shares of the pharmacy operator’s stock worth $105,000 after purchasing an additional 800 shares during the period. Hedge funds and other institutional investors own 60.57% of the company’s stock.

Shares of WBA opened at $63.53 on Monday. Walgreens Boots Alliance Inc has a fifty-two week low of $61.56 and a fifty-two week high of $83.89. The company has a market cap of $63.00 billion, a P/E ratio of 12.46, a price-to-earnings-growth ratio of 1.03 and a beta of 1.15. The company has a current ratio of 0.90, a quick ratio of 0.45 and a debt-to-equity ratio of 0.44.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Wednesday, March 28th. The pharmacy operator reported $1.73 earnings per share for the quarter, topping the consensus estimate of $1.55 by $0.18. Walgreens Boots Alliance had a net margin of 3.33% and a return on equity of 20.38%. The firm had revenue of $33.02 billion for the quarter, compared to the consensus estimate of $32.20 billion. During the same period in the prior year, the firm earned $1.36 EPS. The firm’s revenue for the quarter was up 12.1% on a year-over-year basis. research analysts forecast that Walgreens Boots Alliance Inc will post 5.92 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 12th. Investors of record on Friday, May 18th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 2.52%. The ex-dividend date is Thursday, May 17th. Walgreens Boots Alliance’s payout ratio is currently 31.37%.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction that occurred on Wednesday, May 2nd. The shares were sold at an average price of $65.56, for a total transaction of $179,372.16. Following the completion of the transaction, the director now owns 13,679 shares in the company, valued at approximately $896,795.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 14.80% of the stock is owned by corporate insiders.

A number of equities research analysts have recently issued reports on the stock. Pivotal Research reduced their price target on shares of Walgreens Boots Alliance from $73.00 to $69.00 and set a “hold” rating on the stock in a research note on Friday, March 23rd. Bank of America assumed coverage on shares of Walgreens Boots Alliance in a research note on Tuesday, February 27th. They issued a “neutral” rating and a $76.00 price target on the stock. Leerink Swann reduced their price target on shares of Walgreens Boots Alliance from $75.00 to $70.00 and set a “market perform” rating on the stock in a research note on Wednesday, May 23rd. Zacks Investment Research raised shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $76.00 price target on the stock in a research note on Wednesday, February 14th. Finally, Jefferies Group set a $85.00 price target on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Tuesday, April 3rd. Two analysts have rated the stock with a sell rating, nine have given a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $82.40.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply